Sunnyvale, CA – Dionex, the leader of monoclonal antibody analysis, is pleased to announce the release of the MAbPac™ SCX-10 column designed specifically for the exceptionally high-resolution, high-efficiency analysis of monoclonal antibodies and associated variants. This new column’s unique nonporous pellicular resin provides unmatched high resolving power, permitting the separation of monoclonal antibody variants that differ by as little as one charged residue. Hydrophobic interactions with the resin are eliminated for very efficient peaks. The column is designed to address the regulatory requirements for biopharmaceutical characterization.

The MAbPac SCX-10 a strong cation exchange column is complimentary to the industry-leading Dionex ProPac® WCX-10 column for monoclonal antibody variant analysis offering an alternative selectivity and will provide higher resolution and efficiency for variant analysis of some monoclonal antibody samples then the ProPac WCX-10 column. The new column is ideal for the high resolution, high efficiency analysis of monoclonal antibodies and associated variants and is available in 4 x 250 mm format.

For more information, visit www.dionex.com.

Dionex (NASDAQ:DNEX) is a global leader in the manufacturing and marketing of liquid chromatography and sample preparation systems, consumables, and software for chemical analysis. The company’s systems are used worldwide in environmental analysis and by the life sciences, chemical, petrochemical, food and beverage, power generation, and electronics industries. Our expertise in applications and instrumentation helps analytical scientists to evaluate and develop pharmaceuticals, establish environmental regulations, and produce better industrial products.